In the race for an effective vaccine against Covid-19, the American company Moderna reported a success yesterday in collaboration with the Swiss company Lonza. In a large-scale clinical study, the vaccine is expected to protect against disease caused by the SARS-CoV-2 virus with an efficacy of 94.5%. Moderna is now seeking rapid emergency approval in the US. An important advantage of this vaccine candidate could be its transportability. While the vaccine from Pfizer/BioNTech must be kept at a constant minus 70 degrees Celsius, the candidate from Moderna/Lonza apparently requires only refrigerator temperature. On the European stock exchanges as well as on Wall Street, the latest success report together with the previously published positive economic data from China and Japan supported the share prices.
The EuroStoxx 50 temporarily reached its highest level since the end of February and closed at 3 466.21 points, just under +1% higher. On the New York Stock Exchange, hopes for another promising corona vaccine lifted the Dow Jones Industrial by +1.6% to 29 950.44 points. The S&P 500 closed +1.16% higher at 3 626.91 points and the technology-heavy Nasdaq 100 recorded a more moderate daily gain of +0.63% as the sector rotation increased again, away from the hot technology stocks and towards the previous corona losers, i.e. growth-sensitive stocks. It was only after the close of the trading session that Tesla shares took off by around +10% after the US electric car manufacturer was included in the S&P 500 stock market index. The company, owned by tech billionaire Elon Musk, has a market value of almost USD 387bn. In Asia, however, the stock markets showed no uniform trend this morning, and futures for the European stock indices signaled somewhat lower prices again after the strong start to the week.
The New York Fed's Empire State Index fell to 6.3 points in November, indicating a slowdown in growth in the industrial region around the Big Apple. On the contrary, analysts had expected an improvement from 10.5 points in October to 13.5 points. After the indicator had initially slumped to a record low of -78.2 points in April against the backdrop of the corona crisis and the lockdowns, the regional industrial sector has recovered over time and is now trading in positive territory or above zero for the fifth month in succession.
According to European Central Bank President Christine Lagarde, the cooperation between monetary and fiscal policy has proven its worth and shows that Europe is capable of overcoming the corona crisis together. “Europe is back“, Lagarde stated.
The German Federal Bank expects a weak end to the year due to the tense pandemic situation and the recent partial lockdowns for Germany's economy. In its monthly report published yesterday, the central bank stated that the economic recovery that was still evident in Q3 would not continue. However, a slump like the one at the beginning of the corona crisis was not to be expected at present.
|14:30||US||Retail Sales (October, m/m)||+1.9%|
|14:30||US||Import Prices (October, y/y)||-1.1%|
|15:15||US||Industrial Production (October, m/m)||-0.6%|
|16:00||US||NAHB Housing Market Index (November)||85.0|
Publisher: LGT Bank (Switzerland) Ltd., Glärnischstrasse 36, CH-8027 Zurich
Editor: Alessandro Fezzi, +41 44 250 78 59, E-Mail: email@example.com
Source: LGT Bank (Switzerland) Ltd.
Risk Disclosure (Disclaimer)
This publication is an advertising material / marketing communication. This publication is for your information only and is not intended as an offer, solicitation of an offer, or public advertisement to buy or sell any investment or other specific product. Its content has been prepared by our staff and is based on sources of information we consider to be reliable. However, we cannot provide any confirmation or guarantee as to its being correct, complete and up to date. The circumstances and principles to which the information contained in this publication relates may change at any time. Information that has been published should therefore not be understood as implying that no change has taken place since its publication or that it is still up to date. The information in this publication does not constitute an aid for decision-making in relation to financial, legal, tax-related or other consulting matters, nor should any investment decisions or other decisions be made on the basis of this information alone. It is recommended that advice be obtained from a qualified expert. Investors should be aware that the value of investments can fall as well as rise. Positive performance in the past is therefore no guarantee of positive performance in the future. Investments in foreign currencies are also subject to fluctuations in exchange rates. We disclaim all liability for any loss or damage of any kind, whether direct, indirect or consequential, which may be incurred through the use of this publication. This publication is not intended for persons subject to legislation that prohibits its distribution or makes its distribution contingent upon an approval. Any person coming into possession of this publication shall therefore be obliged to find out about any restrictions that may apply and to comply with them. In line with internal guidelines, persons responsible for compiling this report are free to buy hold and sell the securities referred to in this report.